One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Transplant Diagnostics Market

移植診断市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2023年


[ 英語タイトル ] Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023


Product Code : MNMHC00109970
Survey : MarketsandMarkets
Publish On : April, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The transplant diagnostics market projected to grow at a CAGR of 7.4%.”
The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.
“The molecular assay technologies segment is poised to be the fastest-growing during the forecast period.”
On the basis of technology, the transplant diagnostics market is segmented into molecular (PCR based assay and sequencing based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such as low turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.

“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%

The global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements, & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage
This report studies the transplant diagnostics market based on technology, product, transplant type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the transplant diagnostics market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the major players in the transplant diagnostics market. The report analyzes the transplant diagnostics market based on technology, product, transplant type, application, end user, and region
• Product Development: Detailed insights on the research and development activities and product launches in the transplant diagnostics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transplant diagnostics across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transplant diagnostics market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transplant diagnostics market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 GEOGRAPHIC SCOPE 20
1.3.3 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY USED FOR THE STUDY 21
1.5 MAJOR MARKET STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 23
2.1.2 PRIMARY DATA 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 PRODUCT-BASED MARKET ESTIMATION 25
2.2.2 PROCEDURE BASED MARKET ESTIMATION 25
2.2.3 PRIMARY RESEARCH VALIDATION 26
2.3 DATA TRIANGULATION 27
2.4 RESEARCH ASSUMPTIONS 28
2.5 RESEARCH LIMITATIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 36
4.1 TRANSPLANT DIAGNOSTICS MARKET OVERVIEW 36
4.2 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 37
4.3 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 38
4.4 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2018 39
4.5 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 40
4.6 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 41
4.7 TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 42

5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
5.2.1 KEY MARKET DRIVERS 44
5.2.1.1 Increasing number of transplant procedures 44
5.2.1.2 Technological advancements in the field of transplant diagnostics 45
5.2.1.3 Increasing public-private funding for target research activities 46
5.2.1.4 Growing burden of infectious diseases 47
5.2.2 KEY MARKET RESTRAINTS 47
5.2.2.1 High procedural cost of NGS and PCR-based diagnostic assays 47
5.2.2.2 Limited reimbursements for target procedures 48
5.2.3 KEY MARKET OPPORTUNITIES 49
5.2.3.1 Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation 49
5.2.3.2 Increasing public awareness about organ donation and transplantation across emerging countries 49
5.2.4 KEY MARKET CHALLENGES 50
5.2.4.1 Significant gap between the number of organ donors and organs required annually 50
5.2.4.2 Procedural and technical limitations associated with donor-recipient screening 51
6 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES 52
6.1 INTRODUCTION 53
6.2 REAGENTS AND CONSUMABLES 54
6.3 INSTRUMENTS 55
6.4 SOFTWARE AND SERVICES 56
7 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 58
7.1 INTRODUCTION 59
7.2 MOLECULAR ASSAYS 61
7.2.1 PCR-BASED MOLECULAR ASSAYS 62
7.2.1.1 REAL-TIME PCR 65
7.2.1.2 Sequence-specific primer-PCR 66
7.2.1.3 Sequence-specific oligonucleotide-PCR 67
7.2.1.4 Other PCR-based molecular assays 68
7.2.2 SEQUENCING-BASED MOLECULAR ASSAYS 69
7.2.2.1 Sanger sequencing 72
7.2.2.2 Next-generation sequencing 73
7.2.2.3 Other sequencing molecular assays 74
7.3 NON-MOLECULAR ASSAYS 75

8 TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 78
8.1 INTRODUCTION 79
8.2 SOLID ORGAN TRANSPLANTATION 80
8.2.1 KIDNEY TRANSPLANTATION 82
8.2.2 LIVER TRANSPLANTATION 83
8.2.3 HEART TRANSPLANTATION 84
8.2.4 LUNG TRANSPLANTATION 85
8.2.5 PANCREAS TRANSPLANTATION 86
8.2.6 OTHER ORGAN TRANSPLANTATIONS 87
8.3 STEM CELL TRANSPLANTATION 87
8.4 SOFT TISSUE TRANSPLANTATION 89
9 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 90
9.1 INTRODUCTION 91
9.2 DIAGNOSTIC APPLICATIONS 91
9.2.1 PRE-TRANSPLANTATION DIAGNOSTICS 93
9.2.1.1 Infectious disease testing 95
9.2.1.2 Histocompatibility testing 96
9.2.1.3 Blood profiling 97
9.2.2 POST-TRANSPLANTATION DIAGNOSTICS 98
9.3 RESEARCH APPLICATIONS 99
10 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 101
10.1 INTRODUCTION 102
10.2 INDEPENDENT REFERENCE LABORATORIES 103
10.3 HOSPITALS & TRANSPLANT CENTERS 105
10.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 106
11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION 108
11.1 INTRODUCTION 109
11.2 NORTH AMERICA 110
11.2.1 US 116
11.2.2 CANADA 118
11.3 EUROPE 120
11.3.1 GERMANY 126
11.3.2 UK 127
11.3.3 FRANCE 130
11.3.4 REST OF EUROPE 132

11.4 ASIA PACIFIC 134
11.4.1 JAPAN 139
11.4.2 CHINA 141
11.4.3 INDIA 143
11.4.4 REST OF ASIA PACIFIC 144
11.5 REST OF THE WORLD 146
12 COMPETITIVE LANDSCAPE 152
12.1 OVERVIEW 152
12.2 MARKET SHARE ANALYSIS 153
12.3 COMPETITIVE SCENARIO 154
12.3.1 KEY PRODUCT LAUNCHES AND ENHANCEMENTS (2014 TO 2018) 154
12.3.2 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014 TO 2018) 155
12.3.3 MAJOR ACQUISITIONS (2014 TO 2018) 155
12.3.4 KEY EXPANSIONS (2014 TO 2018) 156
13 COMPANY PROFILES 157
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 INTRODUCTION 157
13.2 BECTON, DICKINSON AND COMPANY 158
13.3 BIOFORTUNA 161
13.4 BIOMÉRIEUX SA 163
13.5 BIO-RAD LABORATORIES 166
13.6 CAREDX 171
13.7 F. HOFFMAN-LA ROCHE LIMITED 174
13.8 GENDX 178
13.9 HOLOGIC 180
13.10 ILLUMINA 182
13.11 IMMUCOR 186
13.12 LUMINEX 191
13.13 MERCK KGAA 194
13.14 OMIXON 196
13.15 QIAGEN 198
13.16 THERMO FISHER SCIENTIFIC 205
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX 211
14.1 DISCUSSION GUIDE 211
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 217
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 219
14.4 AVAILABLE CUSTOMIZATIONS 219
14.5 RELATED REPORTS 220
14.6 AUTHOR DETAILS 221

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+